Literature DB >> 24217997

Guest editorial: leukemia stem cell.

Koichi Akashi1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24217997     DOI： 10.1007/s12185-013-1459-9

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  4 in total

Review 1.  Modeling normal and malignant human hematopoiesis in vivo through newborn NSG xenotransplantation.

Authors:  Fumihiko Ishikawa
Journal:  Int J Hematol       Date:  2013-11-21       Impact factor: 2.490

Review 2.  TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells.

Authors:  Yoshikane Kikushige; Toshihiro Miyamoto
Journal:  Int J Hematol       Date:  2013-09-18       Impact factor: 2.490

Review 3.  Stem cell maintenance and disease progression in chronic myeloid leukemia.

Authors:  Takahiro Ito
Journal:  Int J Hematol       Date:  2013-04-04       Impact factor: 2.490

Review 4.  Role of DNMT3A, TET2, and IDH1/2 mutations in pre-leukemic stem cells in acute myeloid leukemia.

Authors:  Steven M Chan; Ravindra Majeti
Journal:  Int J Hematol       Date:  2013-08-15       Impact factor: 2.490
  4 in total
  1 in total

1.  Paroxysmal nocturnal hemoglobinuria induced by the occurrence of BCR-ABL in a PIGA mutant hematopoietic progenitor cell.

Authors:  R Tominaga; T Katagiri; K Kataoka; K Kataoka; R K C Wee; A Maeda; H Gomyo; I Mizuno; T Murayama; S Ogawa; S Nakao
Journal:  Leukemia       Date:  2015-10-06       Impact factor: 11.528
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.